Intravenous highdose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine.
The opposition to methadone nevertheless continued unabated, but despite this the programme was gradually expanded.
It can easily be contaminated, and the intravenous bag of methadone is relatively unstable and needs to be changed frequently.
For reasons of comparability, only patients engaged in a methadone maintenance programme were included.
Factors associated with illegal drug use among older methadone clients.
This study focused on the use of methadone in terminal delirium.
Finally, documentation is an important component of successful parenteral methadone treatment for pain.
This is an open-label feasibility study of a model to evaluate sublingual methadone for cancer-related breakthrough pain.
